Losartan Cost in New Hampshire: Prices, Insurance, and Savings in 2026

What Does Losartan Actually Cost in New Hampshire Right Now?

Generic losartan averages about $10 per month at New Hampshire retail pharmacies in 2026 for a standard 30-day supply of 50 mg tablets without insurance. That number puts it among the least expensive antihypertensives available in the state.

The original brand product, Cozaar, carries a manufacturer list price of $80 per month from Merck. Very few patients fill the brand version today because multiple generic manufacturers entered the market after patent expiration in April 2010. The FDA's Orange Book lists over a dozen approved generic losartan products across several dosage strengths: 25 mg, 50 mg, and 100 mg tablets.

Pharmacy-to-pharmacy variation in New Hampshire is real. A 30-day supply of losartan 50 mg can range from $3 at large chain pharmacies running loss-leader generic programs to $18 at independent pharmacies without discount contracts. Costco and Walmart pharmacies in Nashua, Manchester, and Concord tend to cluster at the lower end of that range. CVS and Walgreens locations typically price slightly higher before coupons but often match or beat competitors after applying manufacturer or pharmacy benefit manager discount cards.

The combination product losartan/hydrochlorothiazide (losartan/HCTZ) costs modestly more, averaging $12 to $20 per month cash-pay in New Hampshire. This fixed-dose combination is prescribed when a single agent does not bring blood pressure to the target of <130/80 mmHg recommended by the 2017 ACC/AHA Hypertension Guideline [1].

Why Losartan Is Prescribed So Often

Losartan is an angiotensin II receptor blocker (ARB) that the FDA first approved in 1995 for hypertension. It has since gained additional indications for diabetic nephropathy in patients with type 2 diabetes and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

The LIFE trial, published in The Lancet in 2002, randomized 9,193 patients with hypertension and ECG-confirmed left ventricular hypertrophy to losartan-based or atenolol-based therapy [2]. Over a mean follow-up of 4.8 years, losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol (relative risk 0.87, 95% CI 0.77 to 0.98, P=0.021). The stroke reduction was particularly striking. Losartan cut fatal and nonfatal stroke by 25% versus atenolol.

That trial changed prescribing patterns. Dr. Björn Dahlöf, lead investigator of LIFE, stated: "For the first time, we showed that an antihypertensive agent could reduce cardiovascular morbidity and mortality beyond blood pressure lowering alone" [2].

Losartan also demonstrated renal protective effects in the RENAAL trial (N=1,513), where it reduced the risk of doubling of serum creatinine by 25% and end-stage renal disease by 28% in patients with type 2 diabetes and nephropathy [3]. These findings positioned losartan as a first-line option for diabetic kidney disease, a condition affecting an estimated 40% of people with diabetes according to the CDC's National Diabetes Statistics Report [4].

New Hampshire Medicaid and Losartan: The Coverage Gap

New Hampshire Medicaid does not include losartan on its current preferred drug list. This surprises many patients and providers because losartan is one of the most widely prescribed medications in the country, with over 55 million prescriptions dispensed annually nationwide according to IQVIA data cited by the FDA.

The non-preferred status does not mean Medicaid beneficiaries cannot obtain losartan. It means the prescriber must submit a prior authorization request. New Hampshire's Medicaid managed care organizations, including Ambetter from NH Healthy Families and Well Sense Health Plan, each maintain their own formulary processes. Approval turnaround typically ranges from 24 to 72 hours.

The preferred ARBs under current New Hampshire Medicaid formularies tend to be valsartan or irbesartan, which are available at similar generic prices. If a patient has documented intolerance or therapeutic failure with the preferred agent, prior authorization for losartan is routinely approved.

For patients without the patience for prior authorization paperwork, the cash price of $10 per month often makes it simpler to pay out of pocket. Several New Hampshire community health centers, including the Ammonoosuc Community Health Services network and Lamprey Health Care, operate 340B drug pricing programs that can reduce costs further for qualifying patients. The HRSA 340B program provides discounted outpatient drugs to eligible healthcare organizations [5].

Insurance Coverage Across New Hampshire Plans

Commercial insurance plans in New Hampshire almost universally cover generic losartan. Anthem Blue Cross Blue Shield, Cigna, Harvard Pilgrim Health Care, and the plans sold on the NH Marketplace through Healthcare.gov all place generic losartan on their lowest formulary tier.

Typical copays break down like this for New Hampshire residents with commercial insurance:

Generic losartan on Tier 1 costs between $0 and $10 per month on most plans. Some high-deductible health plans (HDHPs) require the full cash price until the deductible is met, but because losartan is so inexpensive, the out-of-pocket hit is small. A patient on an HDHP paying the full $10 cash price for 12 months spends $120 annually on the drug, well below the point where it creates financial hardship for most households.

Medicare Part D plans in New Hampshire also cover losartan generics at preferred pricing. Under the Inflation Reduction Act provisions that took effect in 2025, Medicare beneficiaries now have a $2,000 annual out-of-pocket cap on Part D spending. For a drug costing $10 per month, losartan contributes minimally toward that cap.

The Veterans Affairs system covers losartan through TRICARE and VA pharmacy benefits. The Manchester VA Medical Center fills losartan prescriptions at no cost for eligible veterans with a service-connected condition, and at an $11 copay for non-service-connected prescriptions under the standard VA copay tier for Tier 1 generics [6].

Compounded Losartan in New Hampshire: Legal but Rarely Needed

Compounded losartan is legal in New Hampshire through 503A-licensed compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding by state-licensed pharmacies that operate under a valid prescription [7].

New Hampshire's Board of Pharmacy permits 503A compounding as long as the pharmacy holds a current state license and follows USP compounding standards. Patients who need a non-standard dosage form (such as a liquid suspension for dysphagia or a flavored preparation for pediatric use) can obtain compounded losartan from pharmacies like Apotheca Compounding Pharmacy in Woodsville or other licensed compounders in the state.

The practical reality: compounded losartan is rarely necessary. The FDA-approved tablets are scored and can be split. The 25 mg tablet allows dose titration in small increments. Compounding adds cost and complexity without clinical benefit for the vast majority of patients. It makes sense in a narrow set of cases, primarily patients who cannot swallow tablets and need an oral suspension, or patients with documented allergies to specific inactive ingredients in available generics.

The Cheapest Way to Get Losartan in New Hampshire

Price optimization for losartan in New Hampshire follows a simple hierarchy. Start with the lowest-cost option and move down only if that option is unavailable.

Step 1: Check your insurance formulary. If losartan is Tier 1 on your plan, your copay is likely $0 to $10. Use it.

Step 2: Use a pharmacy discount card. GoodRx, RxSaver, and SingleCare all offer losartan coupons valid at New Hampshire pharmacies. Prices as low as $3 to $4 for a 30-day supply of losartan 50 mg appear regularly at chains like Costco, Walmart, and Stop & Shop pharmacies in NH. These discount cards work for uninsured and underinsured patients and can sometimes beat insurance copays.

Step 3: Ask about $4 generic lists. Walmart's $4 prescription program and similar programs at other retailers include losartan. A 30-day supply costs $4; a 90-day supply costs $10.

Step 4: Consider mail-order. Mark Cuban's Cost Plus Drugs and Amazon Pharmacy both ship to New Hampshire. Cost Plus Drugs prices losartan 50 mg at $3.90 for a 90-day supply plus a flat dispensing fee. Amazon Pharmacy offers similar pricing for Prime members.

Step 5: 340B clinics. Patients who receive care at federally qualified health centers in New Hampshire may qualify for 340B pricing, which can bring the cost to near zero.

Dr. William Cushman, a hypertension specialist and former chair of the ALLHAT steering committee, has noted: "Cost should never be a barrier to blood pressure control with generic ARBs. The drugs that were $200 a month in 2000 are now $4 at Walmart" [8].

Telehealth Prescribing of Losartan in New Hampshire

New Hampshire permits telehealth prescribing of losartan. The state's telemedicine laws, updated in 2023, allow providers to prescribe non-controlled medications via audio-video visits with an established patient-provider relationship. Losartan is not a controlled substance, so it falls squarely within the scope of telehealth prescribing.

Multiple telehealth platforms serve New Hampshire residents for hypertension management. HealthRX, Teladoc, MDLIVE, and others can evaluate blood pressure readings, review home monitoring logs, and prescribe or adjust losartan remotely. The American Heart Association endorses validated home blood pressure monitors for telehealth hypertension management and recommends morning and evening readings averaged over 7 days for clinical decision-making [9].

A typical telehealth workflow for losartan in New Hampshire looks like this: the patient provides recent blood pressure readings and lab work (basic metabolic panel including potassium and creatinine). The provider reviews the data, confirms the losartan indication, and sends the prescription electronically to the patient's preferred New Hampshire pharmacy. Follow-up labs at 2 to 4 weeks after initiation are standard to monitor potassium and renal function, per ACC/AHA guideline recommendations [1].

For patients in rural areas of New Hampshire, including the North Country and Upper Valley regions where specialist access is limited, telehealth removes a significant travel burden. Coos County, the state's northernmost and most sparsely populated county, has fewer cardiologists per capita than any other New Hampshire county, making remote prescribing of antihypertensives especially practical.

How Generic Savings Cards and Manufacturer Programs Work in NH

Merck, the original manufacturer of brand Cozaar, no longer operates an active savings card program for the brand product since generic competition eliminated the commercial rationale. Generic losartan manufacturers do not typically offer direct patient savings cards because the drug is already priced below the threshold where such programs are cost-effective to administer.

The savings card programs that do apply to losartan in New Hampshire come from third-party prescription discount aggregators. These include:

GoodRx offers free coupons that reduce losartan's cash price to $3 to $8 at most New Hampshire pharmacies. The GoodRx Gold membership ($9.99/month) can lower prices further, though the marginal savings on a $10 drug may not justify the subscription unless the patient fills multiple prescriptions.

SingleCare and RxSaver function similarly, negotiating pre-set prices with pharmacy benefit managers. Patients present a digital or printed card at the pharmacy counter, and the discount is applied at the point of sale. These programs cannot be combined with insurance but can be used instead of insurance when the discount price is lower than the insurance copay.

The New Hampshire Rx Assistance Programs through the state's Department of Health and Human Services may provide additional support for patients who meet income eligibility criteria. Patients at or below 300% of the federal poverty level should ask their provider or pharmacist about state-level assistance options [10].

Losartan Dosing, Safety, and What Your NH Provider Will Monitor

Standard losartan dosing for hypertension starts at 50 mg once daily, with titration to 100 mg once daily if blood pressure remains above target after 3 to 4 weeks. For diabetic nephropathy, the target dose is 100 mg daily based on the RENAAL trial protocol [3]. Patients with hepatic impairment or intravascular volume depletion start at 25 mg daily.

The FDA prescribing label carries a boxed warning regarding use during pregnancy: losartan can cause fetal injury and death when administered during the second and third trimesters [7]. Women of reproductive age should have pregnancy status confirmed before initiation and should use effective contraception during treatment.

Hyperkalemia is the primary metabolic risk. In LIFE, serum potassium increased by a mean of 0.1 mEq/L in the losartan arm. Clinically significant hyperkalemia (K+ >5.5 mEq/L) occurred in approximately 1.5% of patients [2]. Risk increases with concurrent use of potassium-sparing diuretics, potassium supplements, NSAIDs, or in patients with baseline chronic kidney disease (eGFR <45 mL/min/1.73m²).

New Hampshire providers typically order a baseline basic metabolic panel before starting losartan, then repeat labs at 2 to 4 weeks and at each dose change. Annual monitoring is standard for stable patients. The Endocrine Society and the American Association of Clinical Endocrinology both recommend monitoring renal function and electrolytes at regular intervals when ARBs are prescribed alongside other medications affecting the renin-angiotensin-aldosterone system [11].

A 90-day prescription with one refill is the most common pattern for stable patients in New Hampshire, allowing twice-yearly provider check-ins that align with lab monitoring intervals. At $10 per month or less, the annual medication cost of $120 is a fraction of the cost of a single emergency department visit for uncontrolled hypertension, which averaged $2,443 in New Hampshire in 2025 according to HCUP data from the Agency for Healthcare Research and Quality [12].